Upgrade to SI Premium - Free Trial

Seattle Genetics (SGEN) PT Raised to $191 at RBC Capital

September 14, 2020 1:59 PM
RBC Capital analyst Kennen MacKay raised the price target on Seattle Genetics (NASDAQ: SGEN) to $191.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change